Economic evaluation of dengue prevention

Donald S. Shepard and Jose A. Suaya

in Economic Evaluation in Child Health

Published in print October 2009 | ISBN: 9780199547494
Published online February 2010 | e-ISBN: 9780191720055 | DOI:
 Economic evaluation of dengue prevention

More Like This

Show all results sharing this subject:

  • Public Health and Epidemiology


Show Summary Details


Dengue is a mosquito-borne viral disease which threatens half the world's population. This chapter first briefly examines an existing technology, larviciding, to control the mosquito which transmits dengue. It then presents a detailed examination of a new technology for dengue prevention, a potential dengue vaccine, based on previous work. The economic analysis estimates the health benefits of offering dengue vaccination to annual child cohorts in Southeast Asia (a region that has witnessed the highest incidence), determines the annual cost of that strategy, and projects potential revenues to vaccine producers. The economic analysis is conducted using standard approaches to cost-effectiveness analysis to derive the cost per disability-adjusted life year (DALY) averted. Finally, the chapter highlights some methodological challenges that are specific to child health.

Keywords: dengue; larviciding; dengue vaccine; Southeast Asia; cost-effectiveness analysis; child; disability-adjusted life year; DALY

Chapter.  6617 words.  Illustrated.

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.